About

D4DPR is a global voice for licensed health professionals and scientists advocating for evidence-based drug policies and best practices that advance public health, reduce stigma, and minimize harm.

Strategic Vision: Leverage the expertise, compassion, and influence of licensed health professionals and scientists to enact changes in drug policy necessary to improve public health, human rights, social justice, and consumer protections.

Our Platform includes four overlapping categories.
-Maximizing Health and Wellness emphasizes the importance of an open-minded approach to treatment as well as the psychiatric and somatic benefits offered by presently prohibited medications.
-Harm Reduction provides clear and concise policy statements that will guide our approach to drug use and misuse.
-Cannabis continues our ongoing work on cannabis regulation and legalization.
-Psychedelics acknowledges the explosion of clinical research in psychedelic medicine.

Maximizing Health and Wellness
-Access to health promoting interventions and treatment, both abstinence and non-abstinence based, to individuals with drug use problems
-Recognition of the potential health benefits of promising Schedule I drugs, including cannabis and psychedelics
-Federal protection of licensed medical professionals providing evidence-based treatment with Schedule I drugs consistent with state laws, including the discussion of their benefits and risks

Harm Reduction
-Empirically-supported harm reduction efforts (“meeting people where they are”) to promote public safety, protecting individuals using drugs and society
-Protection of the public through overdose prevention centers, syringe services, naloxone distribution, drug-checking, treatment (including opioid agonist therapies), Good Samaritan laws, and other evidenced-based interventions
-Reduction/removal of penalties for drug possession and use

Cannabis
-Government regulation of cannabis production, testing, labeling, distribution, and sales
-Prevention of non-medical underage cannabis use
-Cannabis competency for all medical providers
-Protected rights for limited home cultivation of cannabis
-Reduce public health risks associated with overcommercialization

Psychedelics
-Access to psychedelic medicine for all individuals who can benefit, regardless of socioeconomic status
-Protection of licensed medical professionals utilizing their scope of practice when conducting psychedelic-assisted therapy and care
-Healthcare coverage parity for psychedelic medicine

Our board feels passionate about our new path as we embark on this broader trajectory for our organization. We anticipate a comprehensive engagement that will confront the injustices, damages, and the rising toll of fatalities resulting from drug prohibition. We invite you to join us in our endeavor to foster a more empathetic, empirically-based, and deliberate approach to the complexities of drug use and misuse.